Head and neck squamous cell carcinoma (HNSCC) is a very aggressive disease with a poor
prognosis for advanced-stage tumors. Recent clinical, genomic, and cellular studies have …

Simple Summary Next-generation sequencing of head and neck squamous cell carcinoma
has revealed multiple new gene mutations, while simultaneously confirming the role of …

Background Immune checkpoint inhibitors (ICI) are approved for treatment of recurrent or
metastatic oropharyngeal head and neck squamous cell carcinoma in the first-and second …

Abstract Background Head and Neck Squamous Cell Carcinoma is a malignant tumor with
high morbidity and mortality. The MMP family plays an important role in tumor invasion and …

Background Previous studies have suggested that inflammatory markers (neutrophil-to-
lymphocyte ratio (NLR), lactate dehydrogenase (LDH) and fibrinogen) are prognostic …

Head and neck cancer (HNC) is one of the most common cancers worldwide. Alcohol and
tobacco consumption, besides viral infections, are the main risk factors associated with this …

Simple Summary In recent years, checkpoint inhibitor treatment of tumors has caused a stir.
The response of patients with metastases showed outstanding success for some cancer …

Head and Neck Squamous Cell Carcinoma (HNSCC) is a highly heterogeneous group of
tumors characterized by an incidence of 650,000 new cases and 350,000 deaths per year …

Laryngeal squamous cell carcinoma (LSCC) and hypopharyngeal squamous cell carcinoma
(HPSCC) are two types of head and neck cancers with high incidence rates and relatively …

Background At present, the prognostic significance of programmed cell death receptor
ligand 1 (PD-L1) expression in oropharyngeal squamous cell carcinoma (OPSCC) patients …